AlloVir Stock

allovir.comHealthcare / BioTech & PharmaFunding to Date: $154.35MM

AlloVir is a biotechnology specializing in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.

Register for Details

For more details on financing and valuation for AlloVir, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for AlloVir.

Register Today

Team

Management Team

Ann Leen Ph.D
Chief Scientific Officer & Co-Founder
Juan Vera MD
Co-Founder, Chief Product Development Officer & Board Member
Cliona Rooney Ph.D
Advisor
David Hallal
Chief Executive Officer & Chairman
Helen Heslop MD
Co-Founder & Advisor
Elizabeth Stoner MD
Senior Clinical Advisor
Vikas Sinha
President, Chief Financial Officer & Board Member
Mitchell Finer Ph.D
Advisor

Board Members

John Wilson
Morana Jovan-Embiricos
David Hallal
Malcolm Brenner MD
Ansbert Gadicke
Juan Vera MD
Vikas Sinha

Other companies like AlloVir in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.74B
Updated on: Oct 2, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.